Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03269669
Brief Title: Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

First Submitted : August 30, 2017
First Submitted that Met QC Criteria : August 31, 2017
First Posted : September 1, 2017

Last Update Submitted that Met QC Criteria : September 15, 2021
Last Update Posted : September 16, 2021